Отделение радиотерапии №1

Previously, surgery was the first choice of treatment, followed by chemotherapy and only then radiation therapy (RT). But over the past 20 years, thanks to technological advances, radiotherapy in oncology has reached a new level. For many oncological diseases radiation therapy is indispensable, and according to modern data, from 70 to 80% of patients need it as an independent method or in combination with chemotherapy and surgery. As for the early stages of some localizations radiation therapy can act as an alternative radical type of treatment. RT can completely rid the patient of the tumor by destroying the remaining cancer cells, reducing the risk of the disease recurrence after surgical treatment.

Modern radiotherapy technologies allow us to treat malignant neoplasms with the highest precision. The dose of radiation is directed selectively to the tumor minimally affecting healthy tissue, thus, minimizing the side effects of RT. Radiation therapy is also used to improve the quality of life of a patient with an incurable disease. For example, to reduce the pressure of the tumor on the spinal cord or large vessels, or to restore swallowing function. By irradiating malignant tumors in the region of the spinal cord or spine it is possible to preserve the patient's ability to move. In such cases, radiation therapy reduces pain and gives a chance for a longer life.

Activities:

● Implementation of treatment programs in accordance with current clinical guidelines;
● Preoperative and postoperative conform radiation therapy;
● Conform RT using modern techniques (3DCRT, IGRT, IMRT, VMAT);
● Preoperative topometric evaluation;
● Implementing various types of fractionation;
● Radical courses of radiation therapy with chemotherapy, target therapy;
● Radical courses of combination RT (combining 2 types of RT) in malignancies of female reproductive system with intracavitary and external conform radiation therapy;
● Radical courses of combination RT in prostate cancer (locally advanced process + high risk group) using brachytherapy and external conform radiation therapy;
● Low-dose rate brachytherapy with I-125 in locally advanced prostate cancer;
● Chemoradiation therapy, as well as chemoradiation therapy + targeted drug therapy for the patients with malignant tumors of the head and neck, lungs, cancer of the rectum, esophagus, brain;
● Palliative RT (in advanced cancer processes);
● Symptomatic radiation therapy (exposure to ionizing radiation to reduce the symptoms of the disease – pain management, SVCS, high risk of pathological fracture, spinal cord compression);
● Carrying out rehabilitation activities during and after the RT in presence of secondary changes of internal organs and tissues. Active prophylaxis of the radiation-induced damage.